Genesco (GCO) Cash & Equivalents (2010 - 2026)

Genesco's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $27.1 million for Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 24.71% year-over-year to $27.1 million in Q2 2026; TTM through May 2026 was $27.1 million, a 24.71% increase from a year earlier, with the FY2026 full-year figure at $105.4 million, up 1305.4% from the prior year.
• Cash & Equivalents declined to $27.1 million in Q2 2026 per GCO's latest filing, from $105.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $320.5 million in Q1 2022 and bottomed at $7.5 million in Q1 2025.
• The 5-year median for Cash & Equivalents is $34.4 million (2024), against an average of $61.2 million.
• Across the five-year window, Cash & Equivalents slumped 88.64% in 2022 and jumped 1305.4% in 2026, its largest moves.
• Year by year, Cash & Equivalents stood at $32.1 million in 2022, then plunged by 32.45% to $21.7 million in 2023, then surged by 54.8% to $33.6 million in 2024, then dropped by 19.49% to $27.0 million in 2025, then climbed by 0.33% to $27.1 million in 2026.
• Per Business Quant, the three latest GCO Cash & Equivalents figures stand at $27.1 million (Q2 2026), $105.4 million (Q1 2026), and $27.0 million (Q4 2025).